Man Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $980K | Sell |
70,028
-99,357
| -59% | -$1.39M | ﹤0.01% | 1423 |
|
|
2025
Q1 | $2.3M | Buy |
169,385
+146,950
| +655% | +$2M | 0.01% | 1135 |
|
|
2024
Q4 | $457K | Sell |
22,435
-7,992
| -26% | -$163K | ﹤0.01% | 1549 |
|
|
2024
Q3 | $886K | Sell |
30,427
-7,118
| -19% | -$207K | ﹤0.01% | 1397 |
|
|
2024
Q2 | $872K | Buy |
+37,545
| New | +$872K | ﹤0.01% | 1412 |
|
|
2023
Q4 | – | Hold |
0
| – | -$8.74M | – | 1979 |
|
|
2023
Q3 | – | Sell |
-505,214
| Closed | -$14.9M | – | 673 |
|
|
2023
Q2 | $14.9M | Buy |
+505,214
| New | +$14.9M | 0.05% | 479 |
|
|
2023
Q1 | – | Sell |
-142,929
| Closed | -$3.97M | – | 2062 |
|
|
2022
Q4 | $3.97M | Buy |
142,929
+108,508
| +315% | +$3.02M | 0.01% | 906 |
|
|
2022
Q3 | $1.06M | Buy |
+34,421
| New | +$1.06M | ﹤0.01% | 1247 |
|
|
2021
Q3 | – | Sell |
-5,464
| Closed | -$429K | – | 1851 |
|
|
2021
Q2 | $429K | Sell |
5,464
-53,061
| -91% | -$4.17M | ﹤0.01% | 1602 |
|
|
2021
Q1 | $3.34M | Sell |
58,525
-41,117
| -41% | -$2.35M | 0.01% | 888 |
|
|
2020
Q4 | $8.35M | Sell |
99,642
-51,814
| -34% | -$4.34M | 0.04% | 517 |
|
|
2020
Q3 | $5.43M | Buy |
+151,456
| New | +$5.43M | 0.02% | 766 |
|
|
2018
Q4 | – | Sell |
-10,488
| Closed | -$228K | – | 1949 |
|
|
2018
Q3 | $228K | Buy |
+10,488
| New | +$228K | ﹤0.01% | 1988 |
|